Advertisement Solta Medical wins Chinese approval to market Thermage systems - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Solta Medical wins Chinese approval to market Thermage systems

Solta Medical, a developer of medical device systems for aesthetic applications, has received regulatory clearance to market and sell Thermage systems in China.

Thermage is a non-invasive radiofrequency procedure for tightening and contouring skin.

Stephen Fanning, chairman of the board, president and CEO of Solta Medical, said: “We are excited about the opportunity to market the premier non-invasive procedure for tightening and contouring skin in China. We have also applied for regulatory approvals in China for our Fraxel products and expect upon approval that these products will allow us to address additional opportunities in the Chinese market.”